ACTIVE INGREDIENT
Clove
Clove
Nasal Moisturizer
KEEP OUT OF REACH OF CHILDREN
Nasal moisturizer & Intranasaly
do not use more than directed
2-3 times daily intranasaly
Xylitol
| Class | Version | Type | Effective |
|---|---|---|---|
| CLOVE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59430-101-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2ad0-f424-e053-dadaa90a57ce | Drug Fact |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59430-101-30 | Nose | 30 mL in 1 BOTTLE | AEROSOL | 30 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CLOVE | ACTIVE INGREDIENT | K48IKT5321 | 1 | |
| CLOVE | ACTIVE MOIETY | K48IKT5321 | 1 | |
| Xylitol | INACTIVE INGREDIENT | VCQ006KQ1E | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59430-101 | 59430-101-30 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CLOVE | K48IKT5321 | ACTIB |
| Xylitol | VCQ006KQ1E | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Xylitol | XYLITOL | VCQ006KQ1E | POWDER, FOR SUSPENSION / ORAL | 4223 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | PASTE / ORAL | 180 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | SUSPENSION / ORAL | 1500 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET, ORALLY DISINTEGRATING / ORAL | 360 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | SOLUTION / ORAL | 21600 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET, EXTENDED RELEASE / ORAL | 2752 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | FILM, SOLUBLE / ORAL | 29 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | SUSPENSION, EXTENDED RELEASE / ORAL | 9000 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | GUM, CHEWING / BUCCAL | 11915 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 72 mg | ||
| Xylitol | XYLITOL | VCQ006KQ1E | TABLET / ORAL | 15.04 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ddd6f377-f7dd-445f-8604-4adef24f7ebd | ef870793-3fd5-487a-afe7-c10c3545a950 | 2013-09-27 | Warnings | ddd6f377-f7dd-445f-8604-4adef24f7ebd ef870793-3fd5-487a-afe7-c10c3545a950 |
Adverse event summaries are temporarily unavailable. Other product information remains available.